An Extension Study for Patients Previously Enrolled in Studies With Pelabresib
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Novartis Pharmaceuticals
Novartis Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Novartis Investigative Site
Antwerp, Belgium
Recruiting - Novartis Investigative Site
Bruges, Belgium
Recruiting
- Novartis Investigative Site
Florence, FI, Italy
Recruiting - Novartis Investigative Site
Varese, VA, Italy
Recruiting - Novartis Investigative Site
Novara, Italy
Recruiting
- Novartis Investigative Site
Amsterdam, Netherlands
Recruiting
- Novartis Investigative Site
Cardiff, United Kingdom
Recruiting - Novartis Investigative Site
Glasgow, United Kingdom
Recruiting - Novartis Investigative Site
London, United Kingdom
Recruiting
- University of California la
Los Angeles, California, United States
Gary SchillerRecruiting - Mayo Clinic Jacksonville
Jacksonville, Florida, United States
Candido RiveraRecruiting - Northwestern University
Chicago, Illinois, United States
Brady L SteinRecruiting - Uni of Michigan Health System
Ann Arbor, Michigan, United States
Moshe TalpazRecruiting - Mt Sinai Medical Center
New York, New York, United States
Marina KremyanskayaRecruiting - New York Presbyterian Hospital
New York, New York, United States
Joseph ScanduraRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Aug 2024
- Primary completion
- 2 Jun 2027
- Completion
- 30 Jun 2027
- Last update posted
- 11 Jun 2026
- Registered enrollment
- 50
- Registry id
- NCT06401356
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.